IgA pemphigus as an immune checkpoint inhibitor-associated skin manifestation

Bibliographic Details
Main Authors: Tristan V.M. Bruijn, MD, Anne Geraedts, MD, Carmen A. Vlahu, MD, PhD, Lies.H. Jaspars, MD, PhD, Yannick S. Elshot, MD
Format: Article
Language:English
Published: Elsevier 2024-05-01
Series:JAAD Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512624000857
_version_ 1797210041366872064
author Tristan V.M. Bruijn, MD
Anne Geraedts, MD
Carmen A. Vlahu, MD, PhD
Lies.H. Jaspars, MD, PhD
Yannick S. Elshot, MD
author_facet Tristan V.M. Bruijn, MD
Anne Geraedts, MD
Carmen A. Vlahu, MD, PhD
Lies.H. Jaspars, MD, PhD
Yannick S. Elshot, MD
author_sort Tristan V.M. Bruijn, MD
collection DOAJ
first_indexed 2024-04-24T10:04:17Z
format Article
id doaj.art-80f15fc86d3d4f479699c53e5e0d4633
institution Directory Open Access Journal
issn 2352-5126
language English
last_indexed 2024-04-24T10:04:17Z
publishDate 2024-05-01
publisher Elsevier
record_format Article
series JAAD Case Reports
spelling doaj.art-80f15fc86d3d4f479699c53e5e0d46332024-04-13T04:21:24ZengElsevierJAAD Case Reports2352-51262024-05-01474143IgA pemphigus as an immune checkpoint inhibitor-associated skin manifestationTristan V.M. Bruijn, MD0Anne Geraedts, MD1Carmen A. Vlahu, MD, PhD2Lies.H. Jaspars, MD, PhD3Yannick S. Elshot, MD4Department of Dermatology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, Netherlands; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; Correspondence to: Tristan V.M. Bruijn, MD, Department of Dermatology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Postbus 90203, Amsterdam, 1006 BE, Netherlands.Department of Dermatology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, NetherlandsDepartment of Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, NetherlandsDepartment of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, NetherlandsDepartment of Dermatology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, Netherlands; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlandshttp://www.sciencedirect.com/science/article/pii/S2352512624000857anti-PD-1drug eruptionIgAimmune checkpoint inhibitorimmune-related adverse eventpembrolizumab
spellingShingle Tristan V.M. Bruijn, MD
Anne Geraedts, MD
Carmen A. Vlahu, MD, PhD
Lies.H. Jaspars, MD, PhD
Yannick S. Elshot, MD
IgA pemphigus as an immune checkpoint inhibitor-associated skin manifestation
JAAD Case Reports
anti-PD-1
drug eruption
IgA
immune checkpoint inhibitor
immune-related adverse event
pembrolizumab
title IgA pemphigus as an immune checkpoint inhibitor-associated skin manifestation
title_full IgA pemphigus as an immune checkpoint inhibitor-associated skin manifestation
title_fullStr IgA pemphigus as an immune checkpoint inhibitor-associated skin manifestation
title_full_unstemmed IgA pemphigus as an immune checkpoint inhibitor-associated skin manifestation
title_short IgA pemphigus as an immune checkpoint inhibitor-associated skin manifestation
title_sort iga pemphigus as an immune checkpoint inhibitor associated skin manifestation
topic anti-PD-1
drug eruption
IgA
immune checkpoint inhibitor
immune-related adverse event
pembrolizumab
url http://www.sciencedirect.com/science/article/pii/S2352512624000857
work_keys_str_mv AT tristanvmbruijnmd igapemphigusasanimmunecheckpointinhibitorassociatedskinmanifestation
AT annegeraedtsmd igapemphigusasanimmunecheckpointinhibitorassociatedskinmanifestation
AT carmenavlahumdphd igapemphigusasanimmunecheckpointinhibitorassociatedskinmanifestation
AT lieshjasparsmdphd igapemphigusasanimmunecheckpointinhibitorassociatedskinmanifestation
AT yannickselshotmd igapemphigusasanimmunecheckpointinhibitorassociatedskinmanifestation